Reply to "Measuring Efficacy of Polypharmacy in Schizophrenic Inpatients"

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We welcome all comments on our report, the methodological limitations and tentative conclusions of which are outlined in the Discussion section of the article. A more careful reading of the Method section by Dr. Lindenmayer would have addressed his concern about our using only 1 admission of patients with multiple admissions. In fact, we used all discharges with the diagnosis of schizophrenia in 1995 and 2000. The number of unique patients in these samples was noted in the article.

J Clin Psychiatry 2004;65(8):1148